Type 1 Diabetes Trial, Recruiting NCT06994403 Sponsor: Federico II University Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT06994403
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Study 1

Who might be able to join this trial:

  • People who are male and in good general health (no existing medical conditions)
  • People aged between 18 and 50 years
  • People with a Body Mass Index (BMI) between 18 and 29 (a measure of body weight relative to height)

Who may not be able to join:

  • People who have been diagnosed with diabetes (any type)
  • People living with any long-term or progressive illness
  • People with any current or ongoing medical condition that could seriously affect their overall health
  • People who have been diagnosed with celiac disease

Study 2

Who might be able to join this trial:

  • People of any gender (male or female)
  • People aged 18 years or older
  • People who have a confirmed diagnosis of type 1 diabetes
  • People who are already using a continuous glucose monitoring (CGM) device — a wearable sensor that tracks blood sugar levels throughout the day

Who may not be able to join:

  • People living with serious long-term illnesses, such as heart disease, kidney failure, liver disease, or hormonal/glandular conditions
  • People with disorders affecting the digestive system
  • People who are pregnant or currently breastfeeding
  • People with dependence on alcohol or drugs

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Giuseppina Costabile, Federico II University

Phone: +39 3333561105

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Federico II University
Registry
ClinicalTrials.gov
Start date
4 September 2023
Est. completion
1 September 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Glycemic Index of Carob-Enriched Durum Wheat Pasta

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov